Publications by authors named "Hae Yun Nam"

TP53-induced glycolysis and apoptosis regulator (TIGAR) regulates redox homeostasis and provides the intermediates necessary for cell growth by reducing the glycolytic rate. During cellular senescence, cells undergo metabolic rewiring towards the glycolytic pathway, along with the development of the senescence-associated secretory phenotype (SASP), also known as the secretome. We observed that TIGAR expression increased during replicative senescence following the in vitro expansion of human mesenchymal stromal cells (MSCs) and that TIGAR knockout (KO) decreased SASP factors and triggered premature senescence with decelerated progression.

View Article and Find Full Text PDF
Article Synopsis
  • Sirtuin 3 (SIRT3) is important for mitochondrial function under oxidative stress, but its role in radioresistant cancer cells, particularly in relation to glucose deprivation, is not well understood.
  • This study investigates SIRT3's impact on cell proliferation and death in two radioresistant head and neck cancer cell lines with different p53 statuses, revealing that SIRT3 levels are linked to cell sensitivity to glucose deficiency.
  • Findings show that the EZH2 protein represses SIRT3 expression in p53-deficient cells, and that regulating SIRT3 through EZH2 could serve as a potential biomarker for personalized treatment options in radiation-resistant cancer patients.
View Article and Find Full Text PDF

Glioblastoma multiforme (GBM), the most aggressive and malignant glioma, has a poor prognosis. Although patients with GBM are treated with surgery, chemotherapy, and radiation therapy, GBM is highly resistant to treatment, making it difficult and expensive to treat. In this study, we analyzed the Gene Expression Profiling Interactive Analysis dataset, the Cancer Genome Atlas dataset, and Gene Expression Omnibus array data.

View Article and Find Full Text PDF

Tumors are composed of subpopulations of cancer cells with functionally distinct features. Intratumoral heterogeneity limits the therapeutic effectiveness of cancer drugs. To address this issue, it is important to understand the regulatory mechanisms driving a subclonal variety within a therapy-resistant tumor.

View Article and Find Full Text PDF
Article Synopsis
  • p53 plays a crucial role in maintaining redox homeostasis by regulating glucose and glutamine metabolism, but the specifics of this mechanism remain unclear.
  • Two cancer subclones with different p53 mutations were studied under glucose-deprived and reactive oxygen species (ROS)-prone conditions to understand p53's influence on metabolism and cellular defense.
  • The subclone with functional p53 utilized glutamine more effectively to sustain energy and redox balance, while the p53-deficient subclone struggled with metabolic stress, suggesting p53 status could guide cancer treatment strategies involving metabolic drugs and ROS therapies.
View Article and Find Full Text PDF

Branched-chain amino acid (BCAA) catabolism and high levels of enzymes in the BCAA metabolic pathway have recently been shown to be associated with cancer growth and survival. However, the precise roles of BCAA metabolism in cancer growth and survival remain largely unclear. Here, we found that BCAA metabolism has an important role in human pancreatic ductal adenocarcinoma (PDAC) growth by regulating lipogenesis.

View Article and Find Full Text PDF
Article Synopsis
  • CIP2A is linked to the activation of oncogenic proteins and contributes to the growth of cancer cells, specifically in radioresistant head and neck cancer (HNC) with TP53 mutations.
  • The study found that while radiation alone didn't significantly harm HN31 cancer cells or lower CIP2A levels, combining radiation with rapamycin heightened the cancer cells' sensitivity to radiation by reducing CIP2A expression and promoting cellular senescence.
  • These findings indicate that targeting CIP2A with rapamycin could be a promising therapeutic approach to treat radioresistant HNC that have TP53 mutations by inducing senescence in cancer cells.
View Article and Find Full Text PDF

The role of p53 in genotoxic therapy-induced metabolic shift in cancers is not yet known. In this study, we investigated the role of p53 in the glycolytic shift in head and neck squamous cell carcinoma cell lines following irradiation. Isogenic p53-null radioresistant cancer cells established through cumulative irradiation showed decreased oxygen consumption and increased glycolysis with compromised mitochondria, corresponding with their enhanced sensitivity to drugs that target glycolysis.

View Article and Find Full Text PDF
Article Synopsis
  • Limited research indicates that angiotensin II (Ang II) may contribute to memory problems in heart failure by affecting adult hippocampal neural stem cells (HCNs).
  • Ang II reduces HCN growth and increases cell death through mechanisms involving mitochondrial reactive oxygen species (ROS) and specific signaling pathways.
  • In a heart failure rat model, treating with angiotensin receptor blockers (ARBs) improved spatial memory and reduced neuronal cell death, suggesting ARBs could help address memory issues linked to heart failure.
View Article and Find Full Text PDF

Background: We attempted to elucidate the mechanism of cell death after radiation by studying how β-catenin silencing controls the radiation sensitivity of radioresistant head and neck cancer cells.

Methods: The most radioresistant cancer cell line (AMC-HN-9) was selected for study. Targeted silencing of β-catenin was used on siRNAs.

View Article and Find Full Text PDF

Aims: Cellular senescence and its secretory phenotype (senescence-associated secretory phenotype [SASP]) develop after long-term expansion of mesenchymal stromal cells (MSCs). Further investigation of this phenotype is required to improve the therapeutic efficacy of MSC-based cell therapies. In this study, we show that positive feedback between SASP and inherent senescence processes plays a crucial role in the senescence of umbilical cord blood-derived MSCs (UCB-MSCs).

View Article and Find Full Text PDF

For therapeutic applications of siRNA, there are technical challenges with respect to targeted and systemic delivery. We here report a new siRNA carrier, RNAtr NPs, in a way that multiple tandem copies of RNA hairpins as a result of rolling circle transcription (RCT) can be readily adapted in tumour-targeted and systemic siRNA delivery. RNAtr NPs provide a means of condensing large amounts of multimeric RNA transcripts into the compact nanoparticles, especially without the aid of polycationic agents, and thus reduce the risk of immunogenicity and cytotoxicity by avoiding the use of synthetic polycationic reagents.

View Article and Find Full Text PDF
Article Synopsis
  • * Wnt/β-catenin signaling is crucial for maintaining the self-renewal and differentiation abilities of MSCs, and it appears to play a role in the aging process of these cells, as its expression decreases with prolonged subculture.
  • * Activating Wnt signaling through specific treatments can delay cellular senescence in MSCs, while inhibiting Wnt can promote it; therefore, manipulating this signaling pathway may offer new strategies for enhancing the longevity and
View Article and Find Full Text PDF
Article Synopsis
  • Autophagy is often activated in cancer cells that resist radiation, prompting researchers to study its relationship with TAK1 in this context.
  • The study found that inhibiting TAK1 increased the effectiveness of radiation treatment in MDA-MB231 breast cancer cells by promoting cell death.
  • Overall, the results suggest that targeting TAK1 and autophagy could be a promising approach for improving treatment outcomes in radioresistant breast cancer.
View Article and Find Full Text PDF

Radiotherapy is one of the well-established therapeutic modalities for cancer treatment. However, the emergence of cells refractory to radiation is a major obstacle to successful treatment with radiotherapy. Many reports suggest that inhibitors targeting the mechanistic target of rapamycin (MTOR) can sensitize cancer cells to the effect of radiation, although by which mechanism MTOR inhibitors enhance the efficacy of radiation toward cancer cells remains to be elucidated.

View Article and Find Full Text PDF

Autophagy is frequently activated in radioresistant cancer cells where it provides a cell survival strategy. The mTOR inhibitor rapamycin activates autophagy but paradoxically it also enhances radiosensitivity. In this study, we investigated the mechanisms of these opposing actions in radiation-resistant glioma or parotid carcinoma cells.

View Article and Find Full Text PDF

WNT inhibitory factor-1 (WIF1) is an antagonist of the WNT signaling pathway. We investigated the relationship between WIF1 promoter methylation and regulation of the WNT/β-catenin signaling pathway, tumor grade, and survival in patients with astrocytoma. This study included 86 cases of astrocytoma, comprising 20 diffuse astrocytomas and 66 glioblastomas.

View Article and Find Full Text PDF

The Wnt/β-catenin pathway regulates the viability and radiosensitivity of head and neck squamous cancer cells (HNSCC). Increased β-catenin predisposes HNSCC patients to poor prognosis and survival. This study was conducted to determine the mechanism by which β-catenin regulates the viability of HNSCC.

View Article and Find Full Text PDF

The issue of whether aberrant expression of β1-integrin is associated with cancer progression and development of resistance to cytotoxic therapy is of considerable interest. Studies to date have shown that the anchorage-independent survival of cancer is attributed, in part, to epithelial-to-mesenchymal transition (EMT). Here, we have reported a novel alternative mechanism of anchorage-independent survival of cancer cells.

View Article and Find Full Text PDF

To date, several principal methods are presently used to monitor the autophagic process, but they have some potential experimental pitfalls or limitations that make them not applicable to living cells. In order to improve on the currently developed detection methods for autophagy, we report here fluorescent peptide-conjugated polymeric nanoparticles loaded with a lysosome staining dye in their core. The fluorescent peptide is designed to be specifically cleaved by the Atg4 cysteine protease, which plays a crucial role in autophagy activation.

View Article and Find Full Text PDF

GD2 ganglioside has been identified as a key determinant of bone marrow-derived mesenchymal stem cells (BM-MSCs). Here, we characterized GD2 ganglioside expression and its implications in umbilical cord blood-derived MSCs (UCB-MSCs). Using immune-selection analysis, we showed that both GD2-positive and GD2-negative UCB-MSCs expressed general stem cell markers and possessed mesodermal lineage differentiation potential.

View Article and Find Full Text PDF

The genetic materials for systemic administration meet a number of hurdles before they reach the nucleus of the target cells, such as enzymatic degradation in the bloodstream, extravascularization around the target tissue, endocytosis by the target cells, and endosomal escape of the genes. Therefore, there have been tremendous needs of effective gene carriers that can deliver the genetic materials to the target site. Of numerous approaches, recent studies have demonstrated that the lipid-based emulsion systems have the high potential as non-viral gene carriers: 1 lipid emulsions are biocompatible because their major constituents are composed of the non-toxic oils and amphiphilic lipids; 2 the cationic lipid emulsions can form nano-sized complexes with negatively charged DNAs, through which the genetic materials can be protected from the enzymatic degradation in the body fluids; 3 The emulsion/DNA complexes are shown to be stable in the bloodstream since their surfaces are rarely recognized by the immune-related cells and serum proteins; and 4 the surfaces of the emulsion complexes are readily modified by varying the lipid composition.

View Article and Find Full Text PDF

Polymeric nanoparticle-based carriers are promising agents for the targeted delivery of therapeutics to the intracellular site of action. To optimize the efficacy in delivery, often the tuning of physicochemical properties (i.e.

View Article and Find Full Text PDF

To make stable and biocompatible non-viral gene carriers for therapeutic gene therapy, we developed a cationic lipid-based emulsion (CLE) prepared by an oil-in-water (O/W) emulsion method, wherein squalene oil was used as an oil core and the cationic lipid, 1,2-dioleoyl-sn-glycero-3-trimethylammonium-propane (DOTAP), was employed as an emulsifier. To evaluate in vivo characteristics such as toxicity and time-dependent gene expression, a bioluminescence reporter gene in pCMV-luc plasmid DNA was simply mixed with CLE in aqueous condition, resulting in a CLE/DNA complex. The CLE/DNA complex was optimized to form a compact and stable nano-sized particle by adding different amounts of plasmid DNA, and an optimal cationic lipid-to-DNA (C/D) weight ratio of 4 was identified.

View Article and Find Full Text PDF
Article Synopsis
  • Antiangiogenic peptide drugs, targeting integrins on blood vessel cells, show potential for cancer therapy, but their quick breakdown in the body limits their effectiveness.
  • Researchers developed self-assembled glycol chitosan nanoparticles (RGD-HGC) to improve delivery of RGD peptide, achieving high encapsulation efficiency and prolonged release of the drug over a week.
  • In studies, RGD-HGC demonstrated significant antiangiogenic effects and reduced tumor growth compared to standard RGD peptide due to its ability to deliver the drug more effectively in cancer treatment.
View Article and Find Full Text PDF